Today’s Market Winners and Losers
The stock market is mixed on Tuesday, with the Dow Jones Industrial Average down 0.01%, the Nasdaq up 0.21% and the S&P up 0.51%. Tuesday's winners include a telecommunications company ...Read Full Story »
Posts related to ‘Cell Therapeutics’
Read Full Story »
Can A European Approval of Pixantrone Save Cell Therapeutics? (CTIC)
Cell Therapeutics, Inc. (NASDAQ: CTIC) is about as controversial of a biotech stock as there can be. It often traded huge volume around drug approval or study news, and shares ...Read Full Story »
Rethinking Cell Therapeutics… As An Acquirer? (CTICD)
Cell Therapeutics, Inc. (NASDAQ: CTICD) has long been a controversial stock. It has brought many rewards for investors and it has also brought much pain to investors. We recently featured ...Read Full Story »
-
Categories:
- 24/7 Wall St. Wire (9924)
- Accounting (510)
- Active Trader (4398)
- Aerospace & Defense (230)
- Alternative Energy (1059)
- Analyst Calls (5073)
- Autos (1472)
- Banking & Finance (3789)
- Bankruptcy (282)
- Buffett (339)
- Calendar (421)
- Casinos & Hotels (99)
- Commodities & Metals (1360)
- Consumer Product (795)
- Corporate Governance (1989)
- Dividends & Buybacks (923)
- Earnings (4146)
- Economy (3696)
- Editor's Picks (516)
- ETFs & Mutual Funds (822)
- General (3836)
- Healthcare (1433)
- Housing (1035)
- Industrials (630)
- Infrastructure (601)
- International Markets (4169)
- Internet (2194)
- IPOs & Secondaries (1650)
- Jobs (158)
- Labor (655)
- Media (4201)
- Mergers & Acquisitions (2226)
- Oil & Gas (2573)
- Personal Finance (305)
- Politics (822)
- Polls (34)
- Regulation (1162)
- Retail (2582)
- Rumors (1093)
- Services (297)
- Special Report (375)
- Technology (3820)
- Telecom & Wireless (1691)
- Transportation (581)
- Value Investing (763)
